Disease/Infection News

RSS
Two reports highlight the need for effective interventions to prevent excess COVID-19 deaths

Two reports highlight the need for effective interventions to prevent excess COVID-19 deaths

28 Apr 2022
Study investigates intestinal ischemia in COVID-19 patients

Study investigates intestinal ischemia in COVID-19 patients

28 Apr 2022
Study shows public health impact of covid-19 vaccines in the U.S.

Study shows public health impact of covid-19 vaccines in the U.S.

28 Apr 2022
New study predicts which hospitalized COVID-19 patients are at high risk for severe disease

New study predicts which hospitalized COVID-19 patients are at high risk for severe disease

28 Apr 2022
Therapeutic promise of CAR-T cell bispecific engagers against SARS-CoV-2

Therapeutic promise of CAR-T cell bispecific engagers against SARS-CoV-2

28 Apr 2022
Evaluating nano alum as a substitute for conventional alum-based vaccine adjuvant

Evaluating nano alum as a substitute for conventional alum-based vaccine adjuvant

28 Apr 2022
Review aims to deepen the understanding of the role of natural killer cells in COVID-19

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

28 Apr 2022
The added value of adequate immune fitness to the existing approaches to pandemic preparedness

The added value of adequate immune fitness to the existing approaches to pandemic preparedness

28 Apr 2022
Protocols and practices that support breastfeeding during the COVID-19 pandemic

Protocols and practices that support breastfeeding during the COVID-19 pandemic

28 Apr 2022
Acute kidney injury among pediatric COVID-19 patients admitted to the ICU in North America

Acute kidney injury among pediatric COVID-19 patients admitted to the ICU in North America

28 Apr 2022
Researchers investigate O-glycosylation in cells infected with Ebola

Researchers investigate O-glycosylation in cells infected with Ebola

28 Apr 2022
Identification of a SARS-CoV-2 neutralizing human monoclonal antibody with a remarkable broad-spectrum neutralization and protection efficacy

Identification of a SARS-CoV-2 neutralizing human monoclonal antibody with a remarkable broad-spectrum neutralization and protection efficacy

28 Apr 2022
Nearly 60% of Americans infected by Omicron

Nearly 60% of Americans infected by Omicron

28 Apr 2022
Researchers demonstrate the efficiency of T-cell immune response against the Omicron variant

Researchers demonstrate the efficiency of T-cell immune response against the Omicron variant

28 Apr 2022
Scientists explore mixing of unvaccinated and vaccinated and implications for SARS-CoV-2 transmission

Scientists explore mixing of unvaccinated and vaccinated and implications for SARS-CoV-2 transmission

28 Apr 2022
Discovery of novel antibody that targets shared epitope on SARS-CoV-2 variants

Discovery of novel antibody that targets shared epitope on SARS-CoV-2 variants

28 Apr 2022
Excess all-cause deaths during the COVID pandemic in the US

Excess all-cause deaths during the COVID pandemic in the US

27 Apr 2022
Low dose aspirin is downgraded for preventing cardiovascular disease

Low dose aspirin is downgraded for preventing cardiovascular disease

27 Apr 2022
Green tea catechin as pan-coronavirus attachment inhibitor

Green tea catechin as pan-coronavirus attachment inhibitor

27 Apr 2022
Study describes ultra-structure of Nipah virus surface glycoprotein

Study describes ultra-structure of Nipah virus surface glycoprotein

27 Apr 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback